Instructor in Surgery
Harvard Medical School
Chief Medical Officer
The Vascular Care Group/
Mangrove Management Partners
Mangrove Management Partners
Boston, Massachusetts
Presenter
SESSION 18: MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE APPROACH – PART 2
Panelist
SESSION 18: MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE APPROACH – PART 2
Session Moderator
SESSION 41: OPEN AND ENDO TREATMENT OF COMPLEX AAAS (JUXTA, PARA- AND SUPRA-RENAL) AND TAAAS; INTERESTING NEW DEVICES FOR THEIR TREATMENT
Presenter
SESSION 37: MORE ISSUE-RELATED TOPICS IMPORTANT TO VASCULAR SURGEONS AND VASCULAR SPECIALISTS; ISSUES RELATED TO OUTPATIENT CENTERS OR OFFICE-BASED LABS (OBLS) AND AMBULATORY SURGERY CENTERS (ASCS)
Session Moderator
SESSION 56: NEW OR UPDATED EVAR DEVICES FOR AAAS, COMPLEX AAAS, TAAAS OR ARCH TEVARS
SESSION 18: MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE APPROACH – PART 2
The Angiovac Strategy For The Treatment Of PE
10:10 AM - 10:20 AM
Panelist
SESSION 18: MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE APPROACH – PART 2
11:35 AM - 12:00 PM
Session Moderator
SESSION 41: OPEN AND ENDO TREATMENT OF COMPLEX AAAS (JUXTA, PARA- AND SUPRA-RENAL) AND TAAAS; INTERESTING NEW DEVICES FOR THEIR TREATMENT
Presenter
SESSION 37: MORE ISSUE-RELATED TOPICS IMPORTANT TO VASCULAR SURGEONS AND VASCULAR SPECIALISTS; ISSUES RELATED TO OUTPATIENT CENTERS OR OFFICE-BASED LABS (OBLS) AND AMBULATORY SURGERY CENTERS (ASCS)
How To Make Outpatient Vascular Treatment Facilities (OBLs, ASCs) Safe, Effective And Profitable Without Doing Unjustified Procedures: How Can They Make Uniquely Important Vascular Research Contributions
3:46 PM - 3:51 PM
Session Moderator
SESSION 56: NEW OR UPDATED EVAR DEVICES FOR AAAS, COMPLEX AAAS, TAAAS OR ARCH TEVARS